USPTO serial 90283652
ASCENDIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 30, 2021
- Examiner
- BELENKER, ESTHER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ASCENDIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shannon Marie McKeon
Shannon Marie McKeon DYKEMA GOSSETT PLLC1301 K STR., N.W., SUITE 1100WASHINGTON, DC 20005UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Providing consumer product information relating to pharmaceutical products and medical devices; medical cost management; business administrative services for medical referrals; maintaining a registry of certified medical professionals; advertising services to promote public awareness of medical conditions; medical claims management services for patients, namely, receiving and processing transactions that are originated by physicians, hospitals, and ancillary medical care providers; administering discount programs in relation to pharmaceutical products and medical devices, namely, enabling participant members to obtain discounts on the purchase of pharmaceutical products and medical devices; Administering pharmacy reimbursement programs, namely, business administration of pharmacy reimbursement programs; business administration of pharmacy reimbursement programs, namely, assisting customers in obtaining reimbursement under pharmacy reimbursement programs; retail store services and online retail store services featuring pharmaceuticals and medical devices; retail store services and online retail store services featuring pharmaceuticals, namely, advancement of drugs to patients to initiate therapy while benefit or insurance claims are pending; business administration of pharmacy services, namely, administering a quick start program providing patients with limited free supplies of drugs to initiate therapy while obtaining benefits or insurance coverage | ACTIVE | — |
| 036 | Providing information in insurance matters; insurance services, namely, assisting patients in preparing claims and obtaining repayment of medical expenses; insurance administration of prescription drug benefit plans; advancement of funds for covering pharmaceutical and medical expenses; Administering pharmacy reimbursement programs, namely, financial administration of pharmacy reimbursement programs; financial administration of pharmacy reimbursement programs, namely, assisting customers in obtaining reimbursement under pharmacy reimbursement programs; pharmacy benefit management services, namely, administering a quick start program providing patients with limited free supplies of drugs to initiate therapy while obtaining benefits or insurance coverage; pharmaceutical and pharmacy benefit management services, namely, provision of information for patients in relation to obtaining benefits relating to medical treatment and pharmaceuticals; pharmaceutical and pharmacy benefit management services, namely, assisting patients in preparing claims and obtaining benefits; providing information about patient reimbursement programs for patients and insurance coverage for pharmaceuticals and medical devices | ACTIVE | — |
| 038 | Provision of platforms, portals and websites on the Internet for electronic transmission of medical data between patients and their healthcare providers | ACTIVE | — |
| 044 | Medical and healthcare services; Medical testing for diagnostic or treatment purposes; Consultancy relating to medical testing, medicines, health and pharmaceutical products; Providing and sharing of information and advice relating to medical testing, medicine, health and pharmaceutical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ascendis Pharma A/S
- Other trademarks owned by Ascendis Pharma A/S
- Other trademarks owned by Ascendis Pharma A/S
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 038
- Other trademarks in Class 044
- Similar marks named ASCENDIS
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 30, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 14, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 10, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 9, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 5, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 5, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 5, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2021 | ALIE | ASSIGNED TO LIE | — |
| Jul 16, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 1, 2020 | NWAP | NEW APPLICATION ENTERED | — |